Image

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this multicentre observational study is to analyse the treatment strategies and the outcomes for patients with S. maltophilia infections using target trial emulation methodology. The main question it aims to answer is:

• Does combined therapy achieve better results than monotherapy in treating S. maltophilia infections?

Researchers will compare groups receiving monotherapy and combined therapy to see if there are differences in all-cause 30-day mortality.

Eligibility

Inclusion Criteria:

  • Adult patients
  • S. maltophilia infections
  • Different episodes if a new infection ocurred \> 30 days since the index episode

Exclusion Criteria:

  • isolates obtained from patients outside of hospital admission
  • microbiological or clinical colonization
  • hospitalizations shorter than 72 hours since the time zero
  • patients who died in the first 72 hours since the time zero or who were in imminent risk of death
  • polymicrobial infections
  • receipt of inappropriate therapy after the time of the emulated randomization, defined as the absence of in vitro active antimicrobials or the administration of active antimicrobials for less than 48 hours
  • absence of data outcomes

Study details
    Bloodstream Infection
    Pneumonia - Bacterial
    S Maltophilia Infections

NCT07593547

Instituto de Investigación Sanitaria Gregorio Marañón

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.